Send Us your News and/or Sports Tip:

Monash University researchers will “bomb” signage across Melbourne with stickers containing braille to highlight the importance of accessib

Emyria has added a second suite of Emerald Clinics consulting rooms in Perth on the back of continued appointment growth nationally

Imagine a cup. Now reach for it. But you can’t. Not yet. You’ve had a stroke and your brain needs to relearn how to do things you used to d

Dementia peak body congratulates researchers from the Australian Dementia Network (ADNeT) on the release of the first Memory and Cognition

Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the search for ne

Pharnext’s investigational oral combination therapy PXT864 prevents degeneration of motor neurons and their point of contact with...

NS Pharma‘s Viltepso (viltolarsen) is now commercially available in the U.S. for people with Duchenne muscular dystrophy (DMD) amenable to e

The European Commission (EC) approved Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor) to treat cystic fi

One of the biggest mysteries in autism research is understanding how the condition’s discrete set of traits emerges from a multitude of...

AzurRx BioPharma has enrolled the first three patients in its Phase 2b trial investigating MS1819 as a treatment for exocrine pancreatic ins

Innovate UK has given a grant to Reflection Therapeutics to help fund research into new ways of protecting the nervous system from motor neu

Most autistic people — 87 per cent, according to the latest estimate — have some sort of motor difficulty, ranging from an atypical gait to

A Phase 1/2 clinical trial assessing Arrowhead Pharmaceuticals‘ investigational inhaled therapy, ARO-ENaC, for the treatment of cystic fibr

AC Immune is planning to advance its investigational anti-TDP-43 antibody into clinical testing for neurodegenerative diseases, like amyotr

Key points: Figures show almost 470,000 Australians live with an intellectual disability About half of them will experience mental

A new screening system will allow people with hypermobile Ehlers-Danlos syndrome (hEDS) to participate in the worldwide Hypermobile Ehlers-D

Two and a half years ago, a study published in Science Advances detailed how the gene-editing tool CRISPR/Cas-9 repaired genetic mutations r

Researchers have developed the first thread-based flexible patch that can be sewn into clothing to monitor — in real-time — several molecule

New discoveries about the disruption of condensates in the neurodevelopmental disorder Rett syndrome provide insights into how cells compart

With a goal of finding a cure to facioscapulohumeral muscular dystrophy (FSHD) by 2025, the FSHD Society’s third annual Walk & Roll To Cure